iOS app Android app

Tim Spector
Tim Spector is Professor of Genetic Epidemiology at King's College, London, and a consultant physician at Guy's and St. Thomas Hospital. In 1993 he set up the Twins UK register, the largest of its kind in the world, which he continues to direct. He has appeared in numerous television documentaries and is the author of Identically Different: Why We Can Change Our Genes (Overlook Press, August 2013).

Entries by Tim Spector

Have Research Ethics Committees Got It Wrong? A New Study Looks at What Participants in Medical Research Actually Want

(1) Comments | Posted March 24, 2015 | 2:40 PM

Co-authored by Susan E. Kelly and Barbara Prainsack

Traditionally, the "gold standard" of informed consent for participation in medical research entails that participants need to consent to every new research study, which means that they need to be contacted and re-consented each time. Biomedical research today increasingly involves large international...

Read Post

Why the World Keeps Talking About 23andMe

(11) Comments | Posted December 13, 2013 | 5:44 PM

Co-authored with Barbara Prainsack of the Department of Social Science, Health and Medicine, King's College London, UK

Recent action by the FDA against the California-based personal genomics company 23andMe has sparked international attention and bemusement. While some observers agree with the FDA's insistence that the company...

Read Post

Abuse, Adoption and Epigenetics

(29) Comments | Posted July 31, 2013 | 9:47 PM

A recent Guardian article brought to light the harrowing circumstances of parents of adopted children who were left to confront major behavioral problems and violence without adequate institutional support.

Matthew Clore and his wife reluctantly admitted failure when their adopted child was put back into care after...

Read Post

The Sins of Our Grandfathers

(26) Comments | Posted June 21, 2013 | 5:25 PM

A special report by the New Scientist recently caught my eye. The report by Linda Geddes on June 30, 2012 claims that lung cancer is on the rise and focuses on the difficulties of getting funding for an illness that most people view negatively because of its association with smoking.

Read Post